about
Influenza vaccination coverage among medical residents: an Italian multicenter surveyAssessment of timeliness, representativeness and quality of data reported to Italy's national integrated surveillance system for acute viral hepatitis (SEIEVA).Compliance with herpes zoster vaccination in young and adult individuals in two regions of ItalyCombined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.Quality measurement and benchmarking of HPV vaccination services: a new approach.Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort studyRisk groups for hepatitis A virus infection.Hepatitis B: Epidemiology and prevention in developing countries.Preventing and managing herpes zoster: key actions to foster healthy aging.Nosocomial rotavirus infection: An up to date evaluation of European studies.Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.Knowledge and attitude of pregnant women toward flu vaccination: a cross-sectional survey.HIV is associated with thrombophilia and high D-dimer in children and adolescents.Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy.Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit.Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster.Italian Physicians' Opinions on Rotavirus Vaccine Implementation.Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy.Risk management of HBsAg or anti-HCV positive healthcare workers in hospital.The public health value of vaccination for seniors in Europe.Empathy in vaccination counselling: a survey on the impact of a three-day residential courseMonitoring the rate of hospitalization before rotavirus immunization in Italy utilizing ICD9-CM regional databasesViral hepatitis in the Bhutanese population: preliminary results of a seroepidemiological investigationChange from oral poliovirus vaccine to inactivated poliovirus vaccineVaccination strategies against hepatitis A in southern Europe[Plans and vaccination calendar in the Italian regions][Vaccination and vaccines on the Internet: contrary and critical positions][A national vaccination strategy or 22 regional programs?][Immunization in the 3rd, 5th and 11th month of age: an Italian intuition][Recommendations for the use of rotavirus vaccines in industrialized countries][Combined vaccines and simultaneous administration in newborns][Strategies of immunization in Ghana: the experience of a "community-based" health planning in a rural country][Chikungunya: a new epidemy for Europe. Is there a new vaccine coming soon?][A proposal of a triage model to control spreading diseases in public health][Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?][Is it possible to prevent herpes zoster through vaccination?][Vaccination against Hepatitis B Virus in chronic renal disease patients][Screening and vaccination: two synergic tools for the prevention of cervical cancer]["Meningitis epidemic" in Italy in 2007]
P50
Q30358209-1C450DBC-157E-470F-9756-EE42B5F8AD1CQ30913431-145E5595-FC98-4EA6-909D-7807B49C07B5Q33602005-768EF0EC-700C-4381-9D05-8EB03612840EQ34271528-188D028A-F3DD-40C9-BC96-567ACFB086B6Q34271568-8AA17683-D795-46FC-99FC-1A5307B535AEQ34721426-0ECCE6FF-4650-4871-9290-6E2D2D56F5EEQ35126712-BDE71EA0-B172-48AF-BA5C-615C33058239Q35875838-E5889259-BB55-4ABC-AE89-E878B38E1E0AQ38416454-647CA143-5207-4DE1-98E8-94A6EEC8536CQ38835762-8DF66C4C-A222-4C27-83A6-F527AAB41016Q40437635-605CDB83-5D8F-45B0-BC34-061D6983756BQ40915115-2A14ED60-D6F7-4768-8A06-1ECE713108E5Q43157187-AF1A934B-6A35-4981-B189-A2EF35022EA0Q43535701-91C5774A-D068-4A37-A56E-CDFDA85A067CQ45873428-73E6DF12-3E08-4EEA-AF9B-3149B71A61C9Q47277148-F3F1F5D5-5820-4635-A353-7C3D68FCF306Q47630850-33599B07-3CC9-4B12-A055-E2FCEABDF969Q47663403-7E406935-1439-4284-B30F-3ECA6301BE8AQ47842332-FEA0B831-9543-4E57-83F6-470D4FDB18EFQ52046648-577B5617-067A-470F-972D-F4BCDCD2D664Q54242563-821EC669-683C-4797-8D86-DA3BA2F848FDQ57457557-E6E86401-C8A5-42D7-B1E8-BFCE16773566Q61965348-CC4F5B54-216C-4541-A420-45D0A99BC03FQ73235874-E357A213-F2A2-4DFD-AFC2-BEC517E015CEQ78395880-511C3E16-3546-46F8-A79B-789788299496Q78805093-67ABBFBA-824B-453F-9951-06E55808815EQ79501109-265AB21C-12D6-4C24-B28C-30251227F9A2Q79501228-E45280D0-C12C-4FCC-A669-0EF7673BEDA2Q79564550-83DE96E5-202C-4B00-AA21-10F4B44BAD85Q79661127-B3BDD5CE-1967-4F91-B6B1-1C61E8CF86EDQ79668498-FD20F93D-FF43-4782-AE9A-4E3F9298F3F8Q79790494-E2DEC32B-7BA7-4B67-9DCF-02B8BAB655BDQ80078567-0CA2FF8D-9B13-4E9E-BA5B-FC9D8AA0A3B8Q80210211-9924D9D4-200C-4AE2-A293-370DB99245D8Q80542656-0BCB68BF-14E0-43F2-92FB-19704494AB59Q80542662-837D4973-D2B8-461E-AAAB-55E4874AE5B3Q80542681-A5CE16E7-94C9-4FCA-8255-DEB53CA4AF4FQ80989888-5F7BF46A-2BB6-46D1-8537-CF7D39076C0BQ81387906-B7CC7FAB-BEF5-43BF-BF94-2C7BF31EE712Q81395475-5D290045-047D-4F9A-A78C-43EC091EB7E5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Elisabetta Franco
@ast
Elisabetta Franco
@en
Elisabetta Franco
@es
Elisabetta Franco
@nl
type
label
Elisabetta Franco
@ast
Elisabetta Franco
@en
Elisabetta Franco
@es
Elisabetta Franco
@nl
prefLabel
Elisabetta Franco
@ast
Elisabetta Franco
@en
Elisabetta Franco
@es
Elisabetta Franco
@nl
P1153
56511238300
6602618370
P31
P496
0000-0002-1179-4411